Venous thromboembolism risk assessment

Preventable hospital-acquired venous thromboembolism (VTE) is a major cause of death in hospital patients and considerable costs are associated with non-fatal symptomatic VTE and related comorbidities. The first step in preventing death and disability is to identify those who are at risk so that preventative treatments can be used.

How has the rate of VTE risk assessment changed?

There has been an increase in the proportion of admissions assessed for VTE risk across all types of provider of NHS-funded acute care from 2010/11 Q1. They have differing start points but converge to a common level of performance. In 2015/16 Q1, the proportion of admissions receiving a VTE assessment was 96.0% in acute providers and 98.9% in independent sector providers.

About this data

Adherence to national guidance around VTE risk assessment has the potential to save many lives each year.

The data presented here relates to the proportion of adult hospital admissions during the analysis period who were risk assessed for VTE on admission to hospital according to the Department of Health/NICE National Tool.

All providers of NHS-funded acute hospital care (including foundation trusts and independent sector providers) are required to complete the data collection, which was mandated from 1 July 2010.


As a recently-retired physician, I followed this directive as best I could in recent years.
Has there been any impact in outcomes from all this frenetic (& costly) activity - ie morbidity & mortality from VTE? I haven't seen any evidence to support this.

Kit Byatt (not verified)
(changed )

Add new comment